Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Assets Average (2021 - 2026)

Prokidney's (PROK) quarterly Assets Average came in at $270.9 million in Q2 2026, down 30.38% year-over-year from $389.1 million in Q2 2025, and down 13.78% quarter-over-quarter from $314.2 million in Q1 2026.

Analysis

Prokidney (PROK) Assets Average (2021 - 2026) Analysis & Trends

Prokidney (PROK) has reported Assets Average for 6 consecutive years, with $270.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Assets Average fell 30.38% year-over-year to $270.9 million in Q2 2026; TTM through Jun 2026 was $270.9 million, a 30.38% decrease from a year earlier, with the FY2025 full-year figure at $388.3 million, down 9.86% from the prior year.
  • Assets Average was $270.9 million for Q2 2026 at Prokidney, down from $314.2 million in the prior quarter.
  • Over five years, Assets Average peaked at $525.2 million in Q4 2022 and troughed at $145.5 million in Q1 2022.
  • A 5-year average of $395.0 million and a median of $413.9 million in 2024 frame the typical range for Assets Average.
  • Across the five-year window, Assets Average soared 260.06% in 2022 and tumbled 30.38% in 2026, its largest moves.
  • Over 5 years, Assets Average stood at $525.2 million in 2022, then decreased by 16.95% to $436.2 million in 2023, then increased by 4.99% to $457.9 million in 2024, then fell by 24.97% to $343.6 million in 2025, then slipped by 21.16% to $270.9 million in 2026.
  • The last three Assets Average figures came in at $270.9 million (Q2 2026), $314.2 million (Q1 2026), and $343.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 1.45 Bn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - 2.69 Bn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 920.60 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 1.67 Bn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 881.90 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 1.43 Bn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 154.46 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 3.18 Bn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 494.25 Mn
10 Prokidney 346.07 Mn 346.07 Mn - 270.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 270.90 Mn
Mar 31, 2026 314.18 Mn
Dec 31, 2025 343.59 Mn
Sep 30, 2025 361.87 Mn
Jun 30, 2025 389.10 Mn
Mar 31, 2025 423.57 Mn
Dec 31, 2024 457.93 Mn
Sep 30, 2024 486.98 Mn
Jun 30, 2024 443.46 Mn
Mar 31, 2024 404.16 Mn
Dec 31, 2023 436.18 Mn
Sep 30, 2023 468.01 Mn
Jun 30, 2023 489.69 Mn
Mar 31, 2023 506.57 Mn
Dec 31, 2022 525.22 Mn
Sep 30, 2022 391.72 Mn
Jun 30, 2022 250.88 Mn
Mar 31, 2022 145.53 Mn
Dec 31, 2021 145.87 Mn
Sep 30, 2021 126.03 Mn